Polyamine deprivation alters formalin-induced hyperalgesia and decreases morphine efficacy

Life Sciences

Volumn 65, Issue 21, 1999, Pages 2175-2183

  Kergozien, S ^a   Delcros, J G ^a   Desury, D ^a   Moulinoux, J Ph ^a,b  

^a INSERM   (France)

^b Inst de Rech Contre le Cancer IRCC   (France)

Author keywords

c fos; Formalin test; Morphine; Pain related behavior; Polyamines

Indexed keywords

FORMALDEHYDE; MORPHINE; POLYAMINE; PROTEIN C FOS;

ANALGESIA; ANIMAL CELL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; HYPERALGESIA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NERVE CELL NETWORK; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL PROCESSING;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC POLYAMINES; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; MORPHINE; PAIN MEASUREMENT; PROTO-ONCOGENE PROTEINS C-FOS; RATS; SPINAL CORD;

ANIMALIA;

EID: 0033569489     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00482-8     Document Type: Article

References (49)

1. L.J. Marton and A.E. Pegg, Annu. Rev. Pharmacol. Toxicol. 35 55-91 (1995).
2. K. Williams, Biochem. J. 325 289-297 (1997).
3. C. Romano and K. Williams, Modulation of NMDA Receptors by Polyamines, C. Carter (Ed), 82-101, Harcourt Brace & Company, London (1994).
4. J.J. Trout, H. Koenig, A.D. Goldstone, Z. Iqbal, C.Y. Lu and F. Siddiqui, J. Neurochem. 60 352-355 (1993).
5. F. Siddiqui and Z. Iqbal, Neurochem. Res. 19 1421-1429 (1994).
6. H. Koenig, Z. Iqbal, A.D. Goldstone, F. Siddiqui and C.Y. Lu, J. Neurochem. 52 suppl S42 (1989).
7. Z. Iqbal, Mol. Cell. Biochem. 149/150 233-240 (1995).
8. M.J. Hudspith, Br. J. Anaesth. 78 731-747 (1997).
9. S. Genedani, G. Piccinini and A. Bertolini, Life Sci. 34 2407-2412 (1984).
10. T.J. Coderre and I. Van-Empel, Pain 59 345-352 (1994).
11. T.J. Coderre and I. Van-Empel, Pain 59 353-359 (1994).
12. R. Kolhekar, S.T. Meller and G.F. Gebhart, Neuroscience 63 925-936 (1994).
13. M. Bernardi, A. Bertolini, K. Szczawinska and S. Genedani, Eur. J. Pharmacol. 298 51-55 (1996).
14. S. Kergozien, J.-Y. Bansard, J.-G. Delcros, R. Havouis and J.-P. Moulinoux, Life Sci. 58 2209-2215 (1996).
15. S.G. Dennis and R. Melzack, Adv. Pain Res. Ther. 3 747-760 (1979).
16. D. Dubuisson and S.G. Dennis, Pain 4 161-174 (1977).
17. A.H. Dickenson and A.F. Sullivan, Pain 30 349-360 (1987).
18. R.W. Presley, D. Menetrey, J.D. Levine and A.I. Basbaum, J. Neurosci. 10 323- 335 (1990).
19. K.R. Gogas, H.J. Cho, G.I. Botchkina, J.D. Levine and A.I. Basbaum, Pain 65 9-15 (1996).
20. S. Hsu, L. Raine and H. Fanger, Am. J. Clin. Pathol. 75 734-738 (1981).
21. C. Molander, Q. Xu and G. Grant, J. Comp. Neurol. 230 133-141 (1984).
22. J.E. Swett and C.J. Woolf, J. Comp. Neurol. 231 66-77 (1985).
23. J.-M. Besson and A. Chaouch, Physiol. Rev. 67 67-186 (1987).
24. D. Menetrey, Spinal Nociceptive Neurons at the Origin of Long Ascending Pathways in the Rat : Electrological, Anatomical and Immunohistochemical Approaches., J.-M. Besson, G. Guibault and M. Peschanski (Eds), 21-34, Excerpta Medica, Amsterdam (1987).
25. K.R. Gogas, J.D. Levine and A.I. Basbaum, J. Pharmacol. Exp. Ther. 276 801-809 (1996).
26. S. Hunskaar, Pharmacol. Toxicol. 60 167-170 (1987).
27. T. Yamamoto and T.L. Yaksh, Anesthesiology 77 757-763 (1992).
28. F.V. Abbott, K.B.J. Franklin and R.F. Westbrook, Pain 60 91-102 (1995).
29. G.I. Elmer, J.O. Pieper, S.S. Negus and J.H. Woods, Pain 75 129-140 (1998).
30. B.K. Matthies and K.B. Franklin, Pain 51 199-206 (1992).
31. K.B. Franklin and F.V. Abbott, Pharmacol. Biochem. Behav. 46 661-666 (1993).
32. P.A. Ferchmin, P. Discenna, A.M. Borroni, M.M. Velez, E. Rivera and T. Teyler, Brain Res. 601 95-102 (1993).
33. K.E. Gerrish, D.J.M. Fuller, E.W. Gerner and H.L. Gensler, Life Sci. 52 1101- 1108 (1993).
34. T.J. Coderre and R. Melzack, J. Neurosci. 12 3665-3670 (1992).
35. T.J. Coderre and R. Melzack, J. Neurosci. 12 3671-3675 (1992).
36. R.W. Ransom and N.L. Stec, J. Neurochem. 51 830-836 (1988).
37. K. Williams, C. Romano and P.B. Molinoff, Mol. Pharmacol. 36 575-581 (1989).
38. E.M. Davidson, R.E. Coggeshall and S.M. Carlton, Neuroreport 8 941-946 (1997).
39. C. Abbadie, B.K. Taylor, M.A. Peterson and A.I. Basbaum, Pain 69 101-110 (1997).
40. P. Honore, J. Buritova and J.-M. Besson, Brain Res. 732 242-246 (1995).
41. S. Genedani, M. Bernardi, S. Tagliavini and A. Bertolini, Life Sci. 44 525-531 (1989).
42. M.J. Barjavel, J.M. Sherrmann and H.N. Bhargawa, Br. J. Pharmacol. 116 3205-3210 (1995).
43. C. Courteix, P. Bourget, F. Caussade, M. Bardin, F. Coudore, J. Fialip and A. Eschalier, J. Pharmacol. Exp. Ther. 285 63-70 (1998).
44. G.W. Pasternack, A.M. Snowman and S.H. Snyder, Mol. Pharmacol. 11 735-744 (1975).
45. N. Seiler, A. Hardy and J.-P. Moulinoux, Prog. Drug Res. 46 183-241 (1996).
46. R.H. Scott, K.G. Sutton and A.C. Dolphin, Trends Neurosci. 16 153-160 (1993).
47. C.A. Doupnik, N. Davidson and H.A. Lester, Curr. Opin. Neurobiol. 5 268-277 (1995).
48. A.H. Dickenson, Where and How Do Opioids Act?, Vol. 2, G.F. Gebhart, D.L. Hammond and T.S. Jensen (Eds), 525-551, IAPS Press, Seatle (1994).
49. R. Dubner and A.I. Basbaum, Spinal Dorsal Horn Plasticity Following Tissue or Nerve Injury., P.D. Wall and R. Melzack (Eds), 225-241, Churchill Livingstone, Edinburg (1994).